ResourceLife Sciences
Engineering recombinant immune checkpoint proteins for antibody drug development
16 Aug 2022In this scientific poster, ACROBiosystems presents a series of examples of recombinant protein engineering for antibody drug development guided by their structural, biological, and biochemical properties.
Related products
Request Quote for All Products
Immune Checkpoint Proteins
ACROBiosystemsACROBiosystems has developed a full range of immune checkpoint proteins, including co-inhibitory receptors, co-stimulatory receptors, inhibitor screening kits, and others.
Links
Tags
AntibodiesAntibodies are used in techniques such as confocal and fluorescence microscopy, flow cytometry, ELISA, ELISPOT, immunohistochemistry, western blotting and immunopreciptation. Select specific antigen reactivity, high specific affinity, low non-specific binding, monoclonal or polyclonal, primary or secondary antibodies and associated conjugates such as an enzyme or dye for visualization.Recombinant ProteinsDrug DevelopmentDrug development refers to the process of bringing a new drug to market.